Clinical Trials
2
Active:2
Completed:0
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers
Phase 2
Active, not recruiting
- Conditions
- CholangiocarcinomaGastrointestinal CancersPancreatic Ductal AdenocarcinomaColorectal CancerHepatocellular CarcinomaGastric Cancer
- Interventions
- First Posted Date
- 2022-12-08
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- SOFIE
- Target Recruit Count
- 120
- Registration Number
- NCT05641896
- Locations
- 🇺🇸
University of California Los Angeles (UCLA) Health, Los Angeles, California, United States
🇺🇸Massachusetts general hospital, Boston, Massachusetts, United States
🇺🇸BAMF Health, Grand Rapids, Michigan, United States
Study of [68Ga]FAPI-46 PET in Patients with Pancreatic Ductal Carcinoma
Phase 2
Active, not recruiting
- Conditions
- PDAC - Pancreatic Ductal AdenocarcinomaFAP
- Interventions
- First Posted Date
- 2022-03-02
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- SOFIE
- Target Recruit Count
- 60
- Registration Number
- NCT05262855
- Locations
- 🇺🇸
University of California Los Angeles (UCLA) Health, Los Angeles, California, United States
🇺🇸BAMF Health, Grand Rapids, Michigan, United States
🇺🇸Mayo Clinic, Rochester, Minnesota, United States
News
No news found